SLAS News (Dec. 19, 2018) — SLAS, the Society of Laboratory Automation and Screening, is pleased to announce the approval of three new board members. The following candidates will join the board for three-year terms beginning at SLAS2019, February 2-6, in Washington, D.C., and will replace Sabeth Verpoorte, Ian Shuttler and Peter Grandsard, who will be completing their terms.
Michelle Arkin, Ph.D. — University of California San Francisco, San Francisco, CA (USA)
Michelle Arkin is a professor of pharmaceutical chemistry and research director of the Small Molecule Discovery Center at UCSF and has nearly 20 years’ experience in academic pharmaceutical science, specifically in the area of chemical biology and drug discovery. Since 2014, she’s been engaged in a variety of positions with SLAS including as associate chair and chair for the Drug Target Strategies track for the international conference, member of the Scientific Advisory Committee and co-chair of the Scientific Program Committee for SLAS2018. Arkin earned her B.A. from Bryn Mawr College, Bryn Mawr, PA; a Ph.D. from the California Institute of Technology, Pasadena, CA; and completed a postdoctoral fellowship in protein engineering at Genentech Inc.
Sammy Datwani, Ph.D. — Labcyte Inc., San Jose, CA (USA)
Sammy Datwani is a chemical and biomolecular research and development engineer leader with more than 20 years’ experience working with cross-functional groups and multi-national companies to manage and deliver novel life science tools and microdevices designed to advance human health. More specifically he specializes in instrumentation, fluid mechanics, microfluidics, laboratory automation, genomics, systems integration, consumables development, surface chemistry and more. Datwani has served on the SLAS Innovation Award judging panel (2012-2019) as a track chair and associate track chair on the Scientific Program Committee for the SLAS International Conference and Exhibition, and in numerous other roles for prestigious scientific organizations. Datwani received his B.S. and Ph.D. in chemical and biomolecular engineering from the Johns Hopkins University, Baltimore, MD, and his M.S. in chemical engineering from Columbia University, New York, NY. Datwani was recently elected and inducted into the Class of 2018, College of Fellows of the American Institute of Medical and Biological Engineers. Additionally, he is a faculty member in the Department of Biomedical, Chemical, and Materials Engineering at San Jose State University, San Jose, CA.
Hansjoerg Haas, Ph.D. — Thermo Fisher Scientific – Laboratory Automation, Burlington, Ontario (CAN)
Hansjoerg Haas has more than 20 years’ experience as a large-market laboratory automation, robotics and life sciences change agent. As the Senior Director and General Manager of Thermo Fisher Scientific, he oversees strategic and financial planning, marketing and product development, including commercial execution, service and go-to-market strategies for the laboratory automation business unit. Haas is a seasoned volunteer of SLAS and is a current member of the Governance Implementation Task Force. In addition to being a past chair of the Americas Council, Haas was a member of the Association for Laboratory Automation board that implemented the merger between it and the Society of Biomolecular Sciences, which eventually became SLAS. He received his MSci and Ph.D. from Justus Liebig University in Germany.
The SLAS Nominating Committee was led by Daniel G. Sipes, GNF, Chair; and included members Marcie Glicksman, ORIG3N; Dean Ho, UCLA School of Dentistry; Susan Lunte, The University of Kansas; Christian Parker, Novartis Institutes for BioMedical Research Inc.; Burkhard Schaefer, BSSN Software; and Ali Zarrinpar, University of Florida College of Medicine.
Jill Hronek, Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103